Description:
1-(b-D-Xylofuranosyl)uracil, a potent nucleoside analogue, has proven efficacy in treating herpes simplex virus infections as an antiviral agent. Its active mechanism, closely resembling that of natural nucleosides, gives it the ability to impair viral replication, making it a promising therapeutic option for herpes simplex infections.
- Molecular Weight:244.20
- Melting Point:158-158.5°C
- Purity:≥95%
Molecular Formula:
C9H12N2O6
Canonical SMILES:
C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O
InChI:
InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6+,7-,8-/m1/s1
InChIKey:
DRTQHJPVMGBUCF-PXBUCIJWSA-N
Solubility:
Soluble in Ethanol
Appearance:
Powder
Storage: Store at -20°C
Synonyms:
1-beta-D-Xylofuranosyluracil; 1-((2R,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; Xylo-uridine; 1-(beta-D-Xylofuranosyl)uracil; 2,4(1H,3H)-Pyrimidinedione, 1-β-D-xylofuranosyl- Weitere Informationen finden Sie
hier